- Investing Ideas
- /
- Malaysian Pharmaceuticals & Biotech Potentially Undervalued Companies
Malaysian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
4
Companies with a Value score of at least 3, ordered by Value score
4 companies
Duopharma Biotech Berhad
Market Cap: RM 1.3b
An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.35
7D
0%
1Y
-1.5%
Rhone Ma Holdings Berhad
Market Cap: RM 147.6m
An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.
RHONEMA
RM 0.67
7D
2.3%
1Y
-6.3%
Y.S.P. Southeast Asia Holding Berhad
Market Cap: RM 300.7m
Engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally.
YSPSAH
RM 2.12
7D
2.9%
1Y
-14.2%
Kotra Industries Berhad
Market Cap: RM 627.4m
An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.
KOTRA
RM 4.23
7D
-0.7%
1Y
-4.1%